The Weblog for News and Views on the Clinical Trials IndustryClinical Trials Today, Part of the Centerwatch Network
CenterWatch
Clinical Trials Today: The weblog for opinions, news, and views on the Clinical Trials Industry

« Parexel Builds Momentum, Boosts 2008 Outlook | Main | CWWeekly January 28th 2008 Issue »

Clinical Data, Affymetrix in Marketing Deal

Newton, Mass.-based analytical services company Clinical Data signed a service and marketing agreement with Affymetrix, a diagnostic technology company based in Santa Clara, Calif. The agreement allows Clinical Data’s two subsidiaries, Cogenics and Epidauros Biotechnologies AG, to sell Affymetrix’s drug metabolizing enzymes and transporter (DMET) solution. DMET is a method for analyzing the genetics of drug metabolism. It allows sponsors to gain valuable data on pharmacokinetics compared to a patient’s genetic profile.

“We believe that Cogenics’ and Epidauros’ expertise in genetic biomarker discovery and history with ADME studies will greatly enhance the DMET offering by making it more attractive, comprehensive and valuable to pharmaceutical customers seeking to address drug metabolism issues that arise in drug development,” said Pratima Rao, senior director of product marketing at Affymetrix.

Cogenics and Affymetrix collaborated on the development of DMET, which just became available in January.

Comments

Post a comment

Comments are moderated, and will not appear on this weblog until the author has approved them.

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/t/trackback/697361/25629890

Listed below are links to weblogs that reference Clinical Data, Affymetrix in Marketing Deal:

Site Identification Services Product and Service Providers Clinical Trial Results Drugs in Clinical Trials Professional Bookstore Advertising Opportunities